• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评价儿科吗啡群体模型的描述性和预测性性能。

Systematic evaluation of the descriptive and predictive performance of paediatric morphine population models.

机构信息

Division of Pharmacology, Leiden/Amsterdam Center for Drug Research, Leiden, The Netherlands.

出版信息

Pharm Res. 2011 Apr;28(4):797-811. doi: 10.1007/s11095-010-0333-1. Epub 2010 Dec 14.

DOI:10.1007/s11095-010-0333-1
PMID:21153913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3063866/
Abstract

PURPOSE

A framework for the evaluation of paediatric population models is proposed and applied to two different paediatric population pharmacokinetic models for morphine. One covariate model was based on a systematic covariate analysis, the other on fixed allometric scaling principles.

METHODS

The six evaluation criteria in the framework were 1) number of parameters and condition number, 2) numerical diagnostics, 3) prediction-based diagnostics, 4) η-shrinkage, 5) simulation-based diagnostics, 6) diagnostics of individual and population parameter estimates versus covariates, including measurements of bias and precision of the population values compared to the observed individual values. The framework entails both an internal and external model evaluation procedure.

RESULTS

The application of the framework to the two models resulted in the detection of overparameterization and misleading diagnostics based on individual predictions caused by high shrinkage. The diagnostic of individual and population parameter estimates versus covariates proved to be highly informative in assessing obtained covariate relationships. Based on the framework, the systematic covariate model proved to be superior over the fixed allometric model in terms of predictive performance.

CONCLUSIONS

The proposed framework is suitable for the evaluation of paediatric (covariate) models and should be applied to corroborate the descriptive and predictive properties of these models.

摘要

目的

提出了一种用于评估儿科群体模型的框架,并将其应用于两种不同的吗啡儿科群体药代动力学模型。一个协变量模型基于系统协变量分析,另一个基于固定的体表面积比例缩放原则。

方法

该框架中的六个评估标准为:1)参数数量和条件数;2)数值诊断;3)基于预测的诊断;4)η 收缩;5)基于模拟的诊断;6)个体和群体参数估计与协变量的诊断,包括与观察到的个体值相比,对群体值的偏倚和精度的测量。该框架需要内部和外部模型评估过程。

结果

将该框架应用于这两个模型,结果发现由于高收缩导致参数过度拟合和基于个体预测的误导性诊断。个体和群体参数估计与协变量的诊断在评估获得的协变量关系方面非常有信息量。基于该框架,系统协变量模型在预测性能方面优于固定体表面积模型。

结论

所提出的框架适用于儿科(协变量)模型的评估,应应用于证实这些模型的描述性和预测性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/565d/3063866/cd0db09da467/11095_2010_333_Fig5a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/565d/3063866/79b156718e86/11095_2010_333_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/565d/3063866/942f2ec87ad2/11095_2010_333_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/565d/3063866/5454b6079473/11095_2010_333_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/565d/3063866/0a5dd5fbd8f0/11095_2010_333_Fig4a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/565d/3063866/cd0db09da467/11095_2010_333_Fig5a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/565d/3063866/79b156718e86/11095_2010_333_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/565d/3063866/942f2ec87ad2/11095_2010_333_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/565d/3063866/5454b6079473/11095_2010_333_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/565d/3063866/0a5dd5fbd8f0/11095_2010_333_Fig4a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/565d/3063866/cd0db09da467/11095_2010_333_Fig5a_HTML.jpg

相似文献

1
Systematic evaluation of the descriptive and predictive performance of paediatric morphine population models.系统评价儿科吗啡群体模型的描述性和预测性性能。
Pharm Res. 2011 Apr;28(4):797-811. doi: 10.1007/s11095-010-0333-1. Epub 2010 Dec 14.
2
Prediction of morphine clearance in the paediatric population : how accurate are the available pharmacokinetic models?预测小儿人群中的吗啡清除率:现有药代动力学模型的准确性如何?
Clin Pharmacokinet. 2012 Nov;51(11):695-709. doi: 10.1007/s40262-012-0006-9.
3
Evaluation of a morphine maturation model for the prediction of morphine clearance in children: how accurate is the predictive performance of the model?评估吗啡成熟模型预测儿童吗啡清除率的效果:该模型的预测性能有多准确?
Br J Clin Pharmacol. 2011 Jan;71(1):88-94. doi: 10.1111/j.1365-2125.2010.03802.x.
4
Predictive performance of a recently developed population pharmacokinetic model for morphine and its metabolites in new datasets of (preterm) neonates, infants and children.预测近期开发的吗啡及其代谢物群体药代动力学模型在(早产儿)新生儿、婴儿和儿童新数据集的预测性能。
Clin Pharmacokinet. 2011 Jan;50(1):51-63. doi: 10.2165/11536750-000000000-00000.
5
Systematic external evaluation of reported population pharmacokinetic models of vancomycin in Chinese children and adolescents.系统评价中国儿童和青少年万古霉素群体药代动力学模型报告的外部评估。
J Clin Pharm Ther. 2021 Jun;46(3):820-831. doi: 10.1111/jcpt.13363. Epub 2021 Mar 22.
6
Influence of covariate distribution on the predictive performance of pharmacokinetic models in paediatric research.协变量分布对儿科研究中药代动力学模型预测性能的影响。
Br J Clin Pharmacol. 2014 Jul;78(1):145-57. doi: 10.1111/bcp.12322.
7
Prediction of morphine dose in humans.人类吗啡剂量的预测。
Paediatr Anaesth. 2012 Mar;22(3):209-22. doi: 10.1111/j.1460-9592.2011.03782.x. Epub 2011 Dec 28.
8
External evaluation of the predictive performance of seven population pharmacokinetic models for phenobarbital in neonates.对七种新生儿苯巴比妥群体药代动力学模型预测性能的外部评估。
Br J Clin Pharmacol. 2021 Oct;87(10):3878-3889. doi: 10.1111/bcp.14803. Epub 2021 Mar 12.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?儿科患者清除率的异速生长标度:0.75的神奇之处何时消失?
Clin Pharmacokinet. 2017 Mar;56(3):273-285. doi: 10.1007/s40262-016-0436-x.

引用本文的文献

1
Scoping Review of Paediatric Population Pharmacokinetic Models of Morphine.吗啡儿科群体药代动力学模型的范围综述
Clin Pharmacokinet. 2025 May 1. doi: 10.1007/s40262-025-01477-5.
2
All You Need to Know About Allometric Scaling: An Integrative Review on the Theoretical Basis, Empirical Evidence, and Application in Human Pharmacology.关于异速生长比例关系你需要知道的一切:对理论基础、实证证据及其在人类药理学中的应用的综合综述
Clin Pharmacokinet. 2025 Feb;64(2):173-192. doi: 10.1007/s40262-024-01444-6. Epub 2024 Dec 7.
3
Use of Antibiotics in Preterm Newborns.

本文引用的文献

1
Curvature in metabolic scaling.代谢缩放中的曲率。
Nature. 2010 Apr 1;464(7289):753-6. doi: 10.1038/nature08920.
2
The role of population PK-PD modelling in paediatric clinical research.群体 PK-PD 模型在儿科临床研究中的作用。
Eur J Clin Pharmacol. 2011 May;67 Suppl 1(Suppl 1):5-16. doi: 10.1007/s00228-009-0782-9. Epub 2010 Mar 26.
3
Morphine glucuronidation in preterm neonates, infants and children younger than 3 years.早产儿、婴儿和 3 岁以下儿童的吗啡葡萄糖醛酸苷化。
早产儿抗生素的使用
Antibiotics (Basel). 2022 Aug 23;11(9):1142. doi: 10.3390/antibiotics11091142.
4
Quantifying the Pharmacodynamics of Morphine in the Treatment of Postoperative Pain in Preverbal Children.量化吗啡在治疗婴幼儿术后疼痛中的药效学。
J Clin Pharmacol. 2022 Jan;62(1):99-109. doi: 10.1002/jcph.1952. Epub 2021 Sep 17.
5
Clinical pharmacology and dosing regimen optimization of neonatal opioid withdrawal syndrome treatments.新生儿阿片类戒断综合征治疗的临床药理学和剂量方案优化。
Clin Transl Sci. 2021 Jul;14(4):1231-1249. doi: 10.1111/cts.12994. Epub 2021 May 1.
6
Electronic Health Record-Embedded Decision Support Platform for Morphine Precision Dosing in Neonates.电子健康记录嵌入式决策支持平台,用于新生儿吗啡精准给药。
Clin Pharmacol Ther. 2020 Jan;107(1):186-194. doi: 10.1002/cpt.1684. Epub 2019 Dec 11.
7
Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome.儿童造血细胞移植中阿仑单抗(Campath)的群体药代动力学:朝着改善结局的个体化给药。
Clin Pharmacokinet. 2019 Dec;58(12):1609-1620. doi: 10.1007/s40262-019-00782-0.
8
A population pharmacokinetic model of intravenous telavancin in healthy individuals to assess tissue exposure.健康人群中替考拉宁静脉给药的群体药代动力学模型,用于评估组织暴露情况。
Naunyn Schmiedebergs Arch Pharmacol. 2019 Sep;392(9):1097-1106. doi: 10.1007/s00210-019-01647-w. Epub 2019 May 6.
9
Population Pharmacokinetics of Fludarabine in Children and Adults during Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation.异基因造血细胞移植预处理儿童和成人氟达拉滨的群体药代动力学。
Clin Pharmacokinet. 2019 May;58(5):627-637. doi: 10.1007/s40262-018-0715-9.
10
Predicting CYP3A-mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure.预测伴有炎症和器官衰竭的危重新生儿、婴儿、儿童和成人 CYP3A 介导的咪达唑仑代谢。
Br J Clin Pharmacol. 2018 Feb;84(2):358-368. doi: 10.1111/bcp.13459. Epub 2017 Nov 29.
Clin Pharmacokinet. 2009;48(6):371-85. doi: 10.2165/00003088-200948060-00003.
4
Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions.收缩在诊断的经验贝叶斯估计中的重要性:问题与解决方案。
AAPS J. 2009 Sep;11(3):558-69. doi: 10.1208/s12248-009-9133-0. Epub 2009 Aug 1.
5
Application of fixed exponent 0.75 to the prediction of human drug clearance: an inaccurate and misleading concept.将固定指数0.75应用于人体药物清除率预测:一个不准确且具有误导性的概念。
Drug Metabol Drug Interact. 2009;24(1):57-81. doi: 10.1515/dmdi.2009.24.1.57.
6
Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial.吗啡在早产儿和足月儿中的药代动力学和药效学:NEOPAIN试验的次要结果
Br J Anaesth. 2008 Nov;101(5):680-9. doi: 10.1093/bja/aen248. Epub 2008 Aug 23.
7
Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.计算归一化预测分布误差以评估非线性混合效应模型:用于R的npde附加包。
Comput Methods Programs Biomed. 2008 May;90(2):154-66. doi: 10.1016/j.cmpb.2007.12.002. Epub 2008 Jan 22.
8
Mechanism-based concepts of size and maturity in pharmacokinetics.药代动力学中基于机制的大小和成熟度概念。
Annu Rev Pharmacol Toxicol. 2008;48:303-32. doi: 10.1146/annurev.pharmtox.48.113006.094708.
9
Diagnosing model diagnostics.诊断模型诊断
Clin Pharmacol Ther. 2007 Jul;82(1):17-20. doi: 10.1038/sj.clpt.6100241.
10
Prediction of drug clearance in children: impact of allometric exponents, body weight, and age.儿童药物清除率的预测:体表面积指数、体重和年龄的影响。
Ther Drug Monit. 2007 Jun;29(3):271-8. doi: 10.1097/FTD.0b013e318042d3c4.